Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Renal Insufficiency, Chronic × empagliflozin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Renal Insufficiency, Chronic 1 Kidney Neoplasms 1 Heart Failure 1 Cardiotoxicity 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1

Interventions

perflutren 1 finerenone 1 empagliflozin 1 Thalidomide 1 Eplerenone 1 Dexamethasone 1 Bortezomib 1 Bendamustine Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06818305 2025-12-11

EmFin-Nx

Jinling Hospital, China

Phase 2 Terminated

Carcinoma, Renal Cell, Kidney Neoplasms, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡